354 related articles for article (PubMed ID: 20464847)
41. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
42. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
[TBL] [Abstract][Full Text] [Related]
43. The clinical study of extranodal natural killer cell lymphoma, nasal type.
Gui W; Zhao Z; Shen Q; Wang T; Yang B; He J; Li X; Hou S; Zhang L; Zhang Q; Su L
Med Oncol; 2011 Dec; 28 Suppl 1():S367-72. PubMed ID: 21128014
[TBL] [Abstract][Full Text] [Related]
44. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
[TBL] [Abstract][Full Text] [Related]
45. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
46. A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type.
Wang KF; Chang BY; Chen XQ; Liu PP; Wuxiao ZJ; Wang ZH; Li S; Jiang WQ; Xia ZJ
Med Oncol; 2014 Dec; 31(12):318. PubMed ID: 25377661
[TBL] [Abstract][Full Text] [Related]
47. [Sinonasal extranodal natural killer/T-cell lymphoma: a case report and review of recent developments in the management].
Dağoğlu RN; Ozdemir O; Ergen A; Ağaoğlu FY
Kulak Burun Bogaz Ihtis Derg; 2012; 22(3):164-71. PubMed ID: 22663927
[TBL] [Abstract][Full Text] [Related]
48. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
49. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
[TBL] [Abstract][Full Text] [Related]
50. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
Zhang SS; Wei M; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
[TBL] [Abstract][Full Text] [Related]
51. Nasal NK/T-cell lymphoma: where are we now?
Lechowicz MJ
Oncology (Williston Park); 2010 Apr; 24(4):362-3. PubMed ID: 20464849
[No Abstract] [Full Text] [Related]
52. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
Tse E; Kwong YL
Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
[TBL] [Abstract][Full Text] [Related]
53. [Curative effect of nasal type extranodal NK/T-cell lymphoma by sequential chemotherapy combined radiotherapy compared with chemotherapy].
Wang C; Bai H; Xi R; Pan Y; Xu S; Zhang Q; Chen Y; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 27(23):1283-6, 1290. PubMed ID: 24620654
[TBL] [Abstract][Full Text] [Related]
54. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
[TBL] [Abstract][Full Text] [Related]
55. Extranodal NK/T-cell lymphoma, nasal type, with extranasal presentation - a case report and a review of the literature.
Akbar M; Clasen-Linde E; Specht L
Acta Oncol; 2020 Dec; 59(12):1480-1487. PubMed ID: 32689856
[TBL] [Abstract][Full Text] [Related]
56. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
Yamaguchi M; Kwong YL; Kim WS; Maeda Y; Hashimoto C; Suh C; Izutsu K; Ishida F; Isobe Y; Sueoka E; Suzumiya J; Kodama T; Kimura H; Hyo R; Nakamura S; Oshimi K; Suzuki R
J Clin Oncol; 2011 Nov; 29(33):4410-6. PubMed ID: 21990393
[TBL] [Abstract][Full Text] [Related]
57. Natural Killer/T Cell Lymphoma, Nasal Type: A Retrospective Clinical Analysis in North-Western China.
Liang R; Wang Z; Bai QX; Gao GX; Yang L; Zhang T; Gu HT; Dong BX; Shu MM; Hao CX; Zhang N; Chen XQ
Oncol Res Treat; 2016; 39(1-2):45-52. PubMed ID: 26891121
[TBL] [Abstract][Full Text] [Related]
58. Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy.
Li YX; Liu QF; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Liu XF; Zhou LQ; Yu ZH
Cancer; 2011 Nov; 117(22):5203-11. PubMed ID: 21523771
[TBL] [Abstract][Full Text] [Related]
59. Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature.
Wang X; Gong Z; Li SX; Yan W; Song Y
BMC Urol; 2017 Sep; 17(1):77. PubMed ID: 28874193
[TBL] [Abstract][Full Text] [Related]
60. Intensity-modulated radiation therapy followed by GDP chemotherapy for newly diagnosed stage I/II extranodal natural killer/T cell lymphoma, nasal type.
Huang Y; Yang J; Liu P; Zhou S; Gui L; He X; Qin Y; Zhang C; Yang S; Xing P; Sun Y; Shi Y
Ann Hematol; 2017 Sep; 96(9):1477-1483. PubMed ID: 28695246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
